Kymera Therapeutics (KYMR) total assets

Total assets · fiscal 2025
$1.74B

Kymera Therapeutics (KYMR) had total assets of $1.74B at the end of fiscal 2025 (December 31, 2025). That is 78.2% higher than the $978.04M of fiscal 2024. Figures as of 18 Nov 2026, 07:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$1.74B
Change on fiscal 2024
+78.2%
Growth, 5 years
+29.0% a year
Highest on record
$1.74Bfiscal 2025
Lowest on record
$116.70Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kymera Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 29.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was $1.74B in fiscal 2025 and the lowest $116.70M in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

Kymera Therapeutics total assets, year by year

Kymera Therapeutics (KYMR) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$1.74B 78.2% up
2024$978.04M 69.9% up
2023$575.76M 4.5% down
2022$603.13M 0.5% down
2021$605.91M 24.4% up
2020$487.18M 317.5% up
2019$116.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Kymera Therapeutics and comparable companies
CompanyTotal assetsFiscal year
Fresenius Medical Care FMS€31.00B2025
Kymera Therapeutics KYMR$1.74B2025
DaVita DVA$17.48B2025
Halozyme Therapeutics HALO$2.53B2025
Universal Health Services UHS$15.53B2025
Repligen RGEN$2.95B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KYMR

Kymera Therapeutics, figure by figure

Kymera Therapeutics (KYMR) overview: price, valuation and scorecardAll health care companies by market value

Kymera Therapeutics total assets: questions and answers

How large are Kymera Therapeutics's total assets?

Kymera Therapeutics (KYMR) had total assets of $1.74B at the end of fiscal 2025 (December 31, 2025). That is 78.2% higher than the $978.04M of fiscal 2024.

What is the growth rate of Kymera Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 29.0% a year.

What are the highest and lowest total assets figures on record for Kymera Therapeutics?

Across the 7 fiscal years on record (2019–2025), the highest was $1.74B in fiscal 2025 and the lowest $116.70M in fiscal 2019.

How is Kymera Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kymera Therapeutics (KYMR) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/KYMR/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.